We are live on ! Find out more
HSTO

Histogen Inc. Common Stock

Delisted

HSTO was delisted on the 4th of October, 2023.

36 hedge funds and large institutions have $25.1M invested in Histogen Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

6% more funds holding

Funds holding: 3436 (+2)

5% more capital invested

Capital invested by funds: $23.8M → $25.1M (+$1.31M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

10% less call options, than puts

Call options by funds: $763K | Put options by funds: $845K

Holders
36
Holders Change
+2
Holders Change %
+5.88%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
9
Reduced
8
Closed
6
Calls
$763K
Puts
$845K
Net Calls
-$82K
Net Calls Change
+$230K

HSTO Hedge Fund Activity: Q4 2014 in Review

36 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q4 2014, worth a combined $25.1M — up 5.5% from $23.8M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new HSTO positions and 6 closed out — a net gain of 3 holders — while 9 added to existing stakes and 8 trimmed.

The largest buyer was Spark Investment Management, opening a new position worth an estimated $725K. The largest seller was Adage Capital Partners, cutting an estimated $3.83M.

  • 36 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q4 2014, up from 34 in Q3 2014.
  • Funds reported $25.1M of Histogen Inc. Common Stock stock for Q4 2014, up 5.5% quarter-over-quarter.
  • 9 funds opened new Histogen Inc. Common Stock positions in Q4 2014 and 6 closed out, a net change of +3 holders.
  • The largest Histogen Inc. Common Stock buyer in Q4 2014 was Spark Investment Management, an estimated $725K added.
  • The largest Histogen Inc. Common Stock seller in Q4 2014 was Adage Capital Partners, an estimated $3.83M sold.

Based on aggregated 13F filings for Q4 2014.